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in rat liver mounting a hepatic progenitor cell
response for tissue repair
Peter Siig Vestentoft1, Peter Jelnes1, Jesper B Andersen2, Thi Anh Thu Tran1, Tenna Jørgensen1,
Morten Rasmussen1,3, Jette Bornholdt1, Lene Melsæther Grøvdal1, Charlotte Harken Jensen4,5, Lotte Katrine Vogel1,
Snorri S Thorgeirsson2 and Hanne Cathrine Bisgaard1*Abstract
Background: Tissue repair in the adult mammalian liver occurs in two distinct processes, referred to as the first and
second tiers of defense. We undertook to characterize the changes in molecular constituents of the extracellular
matrix when hepatic progenitor cells (HPCs) respond in a second tier of defense to liver injury.
Results: We used transcriptional profiling on rat livers responding by a first tier (surgical removal of 70% of the liver
mass (PHx protocol)) and a second tier (70% hepatectomy combined with exposure to 2-acetylaminofluorene (AAF/
PHx protocol)) of defense to liver injury and compared the transcriptional signatures in untreated rat liver (control)
with those from livers of day 1, day 5 and day 9 post hepatectomy in both protocols. Numerous transcripts
encoding specific subunits of collagens, laminins, integrins, and various other extracellular matrix structural
components were differentially up- or down-modulated (P < 0.01). The levels of a number of transcripts were
significantly up-modulated, mainly in the second tier of defense (Agrn, Bgn, Fbn1, Col4a1, Col8a1, Col9a3, Lama5,
Lamb1, Lamb2, Itga4, Igtb2, Itgb4, Itgb6, Nid2), and their signal intensities showed a strong or very strong correlation
with Krt1-19, a well-established marker of a ductular/HPC reaction. Furthermore, a significant up-modulation and
very strong correlation between the transcriptional profiles of Krt1-19 and St14 encoding matriptase, a component
of a novel protease system, was found in the second tier of defense. Real-time PCR confirmed the modulation of
St14 transcript levels and strong correlation to Krt-19 and also showed a significant up-modulation and strong
correlation to Spint1 encoding HAI-1, a cognate inhibitor of matriptase. Immunodetection and three-dimensional
reconstructions showed that laminin, Collagen1a1, agrin and nidogen1 surrounded bile ducts, proliferating
cholangiocytes, and HPCs in ductular reactions regardless of the nature of defense. Similarly, matriptase and HAI-1
were expressed in cholangiocytes regardless of the tier of defense, but in the second tier of defense, a
subpopulation of HPCs in ductular reactions co-expressed HAI-1 and the fetal hepatocyte marker Dlk1.
Conclusion: Transcriptional profiling and immunodetection, including three-dimensional reconstruction, generated
a detailed overview of the extracellular matrix constituents expressed in a second tier of defense to liver injury.
Keywords: Ductular reaction, Extracellular matrix constituents, First and second tiers of defense, Hepatic progenitor
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Morphologically, the adult liver is characterized by two
epithelial tissue structures, hepatic cords, and bile ducts.
During development, hepatocytes and cholangiocytes,
the cellular epithelial component of the biliary tree, dif-
ferentiate from hepatoblasts and the latter form portal
tubular structures in a complex remodeling process. The
adult liver possesses an exceptional regenerative capacity
in response to injury, which can be accomplished
through two distinct processes, referred to as the first
and second tiers of defense. In the first tier of defense,
the liver can regrow to its original mass and obtain full
functional capacity through division of normally quies-
cent hepatocytes and cholangiocytes [1]. However, when
hepatocytic division is compromised, proliferation of
epithelial cells in the canal of Hering, the most distal
part of the biliary tree, is observed. Because of their abil-
ity to proliferate extensively, express proteins such as
α-fetoprotein (Afp) and Delta-like 1 homolog (Dlk1),
which are normally only found in hepatoblasts and
hepatocytes during liver development, and to differenti-
ate into fully functional hepatocytes or cholangiocytes,
these cells are regarded as proliferating hepatic progeni-
tor cells (HPCs) and constitute the second tier of
defense in the reaction to injury. The canal of Hering is,
therefore, thought to comprise the adult hepatic pro-
genitor cell niche, a protective microenvironment that
serves to maintain and regulate HPC activity [2-6].
As with arrangements defined in stem cell niches of other
organs [7,8], the hepatic progenitor cell niche is thought to
be structurally composed of a facultative stem or progenitor
cell population situated on a basal lamina consisting of a
highly crosslinked extracellular matrix (ECM) of collagens,
laminins, and nidogens. Together with other structural con-
stituents, proteases and their inhibitors, as well as associ-
ated molecules, an ECM microenvironment is created, in
which intimate contact of HPCs with supporting cells, such
as stellate cells, myofibroblasts and macrophages, occurs
[2,3,6]. Upon massive injury to hepatocytes, the niche is
thought to respond by changing the molecular composition
of active signaling pathways and remodeling the ECM
microenvironment affecting both HPCs and supporting
cells. A number of molecules involved in modulating this
response have been identified [9]. Interestingly, they include
several important players in ECM remodeling in liver fibro-
sis, such as connective tissue growth factor [10,11], trans-
forming growth factor-β [12], which is active in ECM
deposition, and matrix metalloproteinases 2, 9, and 12
(MMP-2, MMP-9 and MMP-12) and their inhibitor, tissue
inhibitor of metalloproteinase type 1 (TIMP-1), which is in-
volved in altered matrix degradation [13,14]. Furthermore,
activation of ECM-producing cells and ECM deposition are
reported to occur as an initial phase prior to HPC expan-
sion in the injured liver, and in front of HPCs along theporto-veinous gradient of lobular invasion [15]. Subse-
quently, a key role for laminin in controlling the fate of
HPCs was demonstrated with isolated primary rodent
HPCs seeded on different matrixes, including collagen I,
collagen IV, laminin, and fibronectin, where only inter-
action with laminin was able to promote or sustain expres-
sion of biliary or HPC genes [6]. Altogether, these studies
support the hypothesis of a fundamental role for the ECM
in establishing specific hepatic microenvironments or
niches to regulate the response of HPCs to tissue injury.
However, the exact molecular composition of the ECM in-
volved in a HPC response has yet to be reckoned.
This study was undertaken to characterize the molecu-
lar constituents of the remodeling extracellular matrix
when the hepatic progenitor cell niche responds to liver
injury. For this purpose, we applied the following strat-
egy. First, we compiled a hypothetical list of constituents
involved in extracellular matrix remodeling based on
existing literature (see Table 1). The constituents were
based on four groups of molecules: (i) basal lamina and
ECM structural constituents, including agrin, biglycan,
decorin, elastin, fibrillin, fibronectin, fibulin, collagens,
laminins, integrins, nidogens, and SPARC (secreted pro-
tein, acidic, cysteine-rich); (ii) ECM proteases and inhibi-
tors, including metalloproteinases (MMPs) and their
inhibitors (TIMPs); (iii) other ECM associated mole-
cules, including glypicans and syndecans; and (iv) a
novel protease system, composed of, among others,
matriptase and its cognate inhibitors, hepatocyte growth
factor activator inhibitor (HAI)-1and HAI −2.
Second, to gain detailed information of the underlying
molecular constituents in the remodeling ECM, when a
HPC response is mounted, we used global transcriptional
profiling to identify transcripts that are differentially
expressed in a second tier of defense as compared with a
first tier of defense. It is now agreed that the HPC response
in a second tier of defense can be divided into several dis-
tinct phases [16]. In particular, these phases are well recog-
nized in the AAF/PHx protocol of HPC-dependent liver
regeneration in rat, where they can be distinguished on the
basis of the morphological appearance of HPCs expressing
the fetal liver proteins Afp and Dlk1 [17,18]. In this proto-
col, regeneration from HPCs is achieved through treatment
with 2-acetylaminofluorene to block proliferation of exist-
ing hepatocytes followed by a growth stimulus provided by
a 70% surgical hepatectomy (the AAF/PHx protocol). In
the activation phase, a few proliferating HPCs can be de-
tected in the biliary ductules and canals of Hering. These
early HPCs express cytokeratin 19 (CK19) but not Dlk1
and Afp proteins. In the early proliferation and migration
phase, multiple proliferating CK19-positive HPCs are de-
tected, while cellular expression of Dlk1 and Afp proteins is
rare. However, in the late proliferation and migration phase,
an intricate network of tortuous structures of HPCs
Table 1 Identification of ECM constituents modulated in first and second tiers of defense upon hepatic injury
Protein name Gene
symbol
Modulation of transcriptional profile Product–moment correlation,
coefficient r
First tier of defense
using the PHx protocol
as model system
Second tier of defense
using the AAF/PHx
protocol as model system
Krt1-19-geneX in second tier
of defense using the AAF/PHx
protocol as model system
Hepatic progenitor cell markers
Keratin 19 Krt1-19 ⇅ ↑ * +++++ M
α-Fetoprotein Afp ⇅ ↑ * +++++ M
Epithelial cell adhesion molecule,
EpCam
Tacstd1 ⇅ ↑ * +++++ M
Delta-like homolog 1 Dlk1 ⇅ ↑ * +++++ M
Deleted in malignant brain
tumor 1
Dmbt1 ⇅ ↑ * +++++ M
Glutathione S-transferase, pi Gstp1 ⇅ ↑ * +++++ M
Gap junction protein, α1 (Cx43) Gja1 ⇅ ↑ * +++++ M
Prominin, CD133 Prom1 ⇅ ↑ * +++++ M
CD24 Cd 24 ⇅ ↑ * +++++ M
Vimentin Vim ⇅ ↑ * +++++ M
Proliferating cell nuclear antigen PCNA ↑ * ↑ +++++
Mesenchymal cell markers
Desmin Des ↑ ↑ +++
S100 calcium-binding protein A4 S100a4 ↑ ↑ ++++
Secreted phosphoprotein 1
(osteopontin)
Spp1 ↑ ↑ ++++
Extracellular matrix constituents
Basal lamina and ECM structural constituents
Agrin Agrn ↓ * ↑ * +++++ M
Biglycan Bgn ↓ * ↑ * +++++ M
Decorin Dcn ↑ * ↑ ++++
Elastin Eln ↑ * ↑ +++++
Fibrillin 1 Fbn1 ⇅ ↑ * +++++ M
Fibronectin 1 Fn1 ↓ * ↑ * +++
Fibulin 1 Fbln1 ↓ ↓ ++++
Collagens Col1a1 ↑ ↑ +++++
Col1a2 ↑ ↑ * +++++
Col3a1 ↑ * ↑ * +++++
Col4a1 ⇅ ↑ * +++++ M
Col5a1 ↑ ↑ * +++++
Col5a2 ↑ ↑ * +++++
Col6a1 ↑ ↑ * +++++
Col6a3 ↑ ↑ * +++++
Col8a1 ↓ ↑ * +++++
Col9a3 ⇅ ↑ * +++++ M
Col14a1 ↑ * ↑ * ++++
Col16a1 ↑ ↑ * +++++
Col18a1 ↓ ⇅ +++
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Table 1 Identification of ECM constituents modulated in first and second tiers of defense upon hepatic injury
(Continued)
Laminins Lama2 ↓ * ↑ +++++
Lama5 ⇅ ↑ * ++ M
Lamb1 ⇅ ↑ * +++++ M
Lamb2 ↓ * ↑ * ++++ M
Lamc1 ↑ * ↑ * ++
Lamc2 ⇅ ↑ +++++
Integrins Itga1 ↑ ↓ ++
Itga4 ↓ ↑ * ++++ M
Itga5 ↓ ↓ +++
Itga7 ↓ ↓ * +++
Itgb1 ↑ ↑ * ++++
Itgb2 ↓ * ↑ * +++++ M
Itgb4 ⇅ ↑ * +++++ M
Itgb6 ⇅ ↑ * +++++ M
Itgb7 ↑ ↑ * +++
Nidogens Nid1 ↑ * ↑ * +++++ M
Nid2 ↓ ↑ * +++++ M
Secreted protein, acidic, cysteine-rich,
(osteonectin, SPARC)
Sparc ↑ * ↑ * +++++
ECM proteases and inhibitors
Matrix metallopeptidases Mmp2 ↓ ↓ ++++
Mmp9 ⇅ ⇅ +++
Mmp12 ↑ ↑ * +++++ M
Mmp14 ↓ ↑ * +++
Mmp16 ↑ ↑ +++
Mmp19 ⇅ ↑ * +++
Mmp23 ↑ ↑ * ++++ M
TIMP metallopeptidase inhibitor 1 Timp1 ↑ ↑ * ++
A disintegrin and metalloproteinase
with thrombospondin motifs 1
Adamts1 ↓ ↑ +++++
Suppression of tumorigenicity 14
(matriptase)
St14 ⇅ ↑ * +++++ M
Other ECM associated molecules
Connective tissue growth factor Ctgf ⇅ ↑ * +++++ M
Elastin microfibril interfacer 1 Emilin1 ↑ ↑ * ++++
Glypican 3 Gpc3 ↓ ↑ * +++++ M
Periostin, osteoblast specific factor Postn ↑ ↑ +++++
Syndecans Sdc1 ↑ * ↑ ++++
Sdc2 ↓ * ↓ * +++
Matriptase (St14) network components
Hepatocyte growth factor Hgf ⇅ ↑ * +++
Hepatocyte growth factor
activator
Hgfac ↓ ↓ +++
Hepsin Hpn ↓ ↓ * +++
Kallikrein B, plasma 1 Klkb1 ↓ ↓ * ++++
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Table 1 Identification of ECM constituents modulated in first and second tiers of defense upon hepatic injury
(Continued)
Plasminogen Plg ↓ * ↓ * +++
Plasminogen activator, urokinase Plau ↑ ↑ * +++
Protease, serine, 1 (trypsin 1) Prss1 ⇅ ↑ +++++
Protease, serine, 8 (prostasin) Prss8 ↑ ↑ ++++
Serine peptidase inhibitor,
Kunitz type 1 (HAI-1)
Spint1 ⇅ ↑ +++++
Serine peptidase inhibitor,
Kunitz type 2 (HAI-2)
Spint2 ↓ * ↓ * ++
Serine peptidase inhibitor, clade A
(α-1 antiproteinase), member 1
Serpina1 ↓ * ↓ +++
Serine peptidase inhibitor, clade C
(antithrombin), member 1
Serpinc1 ↓ ↓ +++++
Serine peptidase inhibitor, clade F
(α-2 antiplasmin), member 1
Serpinf2 ↓ * ↓ * +++++
A hypothetical list of constituents involved in extracellular matrix remodeling based on existing literature (See text for details). A list of significantly up- or down-
modulated transcripts is provided in Additional file 1 and a graphic illustration of signal intensities in Additional file 2. Transcriptional profile: ↓, down-modulated;
↑, up-modulated; ⇅, not modulated. Correlation strength: +++++, 0.90 to 1.00, very strong; ++++, 0.70 to 0.89, strong; +++, 0.40 to 0.69, modest; ++, 0.20 to 0.39
weak; + 0.00 to 0.19, very weak. M, transcript levels modulated mainly in the second tier of defense. *Significantly modulated transcripts (P < 0.01, false discovery
rate (FDR) < 5%). The product–moment correlation coefficient (r) was calculated for signal intensities between transcripts of interest relative to Krt1-19, a marker of
the hepatic duct/progenitor cells.
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nates from the canals of Hering and expands into the hep-
atic parenchyma. This is in strong contrast with the cellular
response mounted in a first tier of defense to liver injury,
where existing hepatocytes and cholangiocytes are allowed
to proliferate to reconstitute liver mass and function. In this
study, we therefore performed transcriptional profiling on
rat livers responding with a first-tier (PHx protocol) and a
second-tier (AAF/PHx protocol) defense to injury. Our data
analysis was focused on transcriptional changes in ECM
constituents by a comparison of the transcriptional signa-
ture of untreated rat liver (control) with those from livers
on day 1, day 5 and day 9 post hepatectomy in the two liver
injury protocols. The time points were chosen to represent
the activation phase (day 1), the early proliferation and mi-
gration phase (day 5), and the late proliferation and migra-
tion phase (day 9) of HPCs in a second tier of defense.
Third, using a recently established strategy for com-
puterized three-dimensional analysis [19], we attempted
to reconstruct and visualize the HPC response using the
AAF/PHx protocol and Dlk1 as the immunohistochemi-
cal marker for HPCs, HAI-1 for epithelial cells in the
biliary tree, and entactin/nidogen1 as a structural con-
stituent of the ECM.
And fourth, to test the hypothesis that a selective dif-
ference in expression of ECM constituents would signify
an activated HPC response, the tissue expression and
localization of selected ECM constituents (that is,
Col1a1, laminin, nidogen1, agrin, and integrin-β6) was
analyzed, together with markers for the hepatic progeni-
tor cell response (that is, Dlk1, HAI-1, OV6/CK19) by
dual or triple fluorescence microscopy in differentmodels of first and second tier defenses to liver injury.
The presented data are expected to aid novel research in
extracellular matrix biology and the field of hepatic stem
cells, including a putative progenitor cell niche and its
function in tissue regeneration and fibrogenesis after
liver injury.
Results
Molecular composition of the extracellular matrix during
a hepatic progenitor cell response
To deduce changes in the molecular composition of
ECM during a HPC response we first created a hypo-
thetical list of ECM constituents based on findings in
the literature (see Table 1). We then used global tran-
scriptional profiling to identify transcript levels of ECM
constituents that change when a progenitor cell response
is mounted in response to liver injury. We opted to
study the changes in expression patterns in a second tier
of defense, represented by the AAF/PHx protocol, and
compare the changes to those observed in a first tier of
defense, represented by the PHx protocol. A total of
4,653 and 3,416 transcripts were significantly up- or
down-modulated in the AAF/PHx- and PHx protocols,
respectively, at the nominal 0.01 level of the univariate
test and employing the criteria of a false discovery rate
(FDR) <5% and signal intensities >75 at days 1, 5 or 9 as
compared to control. A decisive factor for choosing
these criteria in the statistical analysis was detection of
Krt1-19, Afp, Tacstd1, Dlk1, Dmbt1, Gstp1, Gja1, Prom1,
Cd24, and Vim as differentially modulated transcripts
because they have previously been shown to correlate
with a HPC response during a second tier of defense in
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scriptional profiles were consistent with a phasic HPC
response, that is, low and high levels of transcripts at
day 1 (activation phase) and day 9 (late proliferation and
migration phase), respectively, while no changes were
found after PHx. Importantly, 39 and 15 transcripts en-
coding ECM constituents were up- or down-modulated
(P < 0.01, FDR <5%) at days 1, 5, or 9, as compared with
controls in the AAF/PHx- and PHx protocols, respect-
ively. Lists of significantly modulated transcripts repre-
senting ECM constituents in the two protocols, as well
as a graphic illustration of signal intensities, are provided
in additional files (see Additional files 1 and 2). A sum-
mary of the transcriptional profiles is presented in
Table 1.
Interestingly, when we calculated the product–moment
correlation coefficients (r) of Krt1-19 signal inten-
sities against the signal intensities of the transcripts
related to the HPC response, very strong correlations
were found (see Table 1 and panel a in Additional file 2).
These findings prompted us to investigate further the
transcriptional profiles of ECM constituents. As summa-
rized in Table 1, the levels of numerous transcripts en-
coding different subunits of collagens (that is, Col1a2,
Col3a1, Col4a1, Col5a1, Col5a2, Col6a1, Col6a3, Col8a1,
Col9a3, Col14a1, Col16a1), laminins (that is, Lamb1,
Lamb2), integrins (that is, Itga4, Itgb2, Itgb4, Itgb6), and
various other ECM structural components (that is, Agrn,
Bgn, Fbn1, Nid1, Nid2, Sparc) showed significant changes
and strong or very strong correlations with Krt1-19 and
thus the HPC response in the second tier of defense.
The levels of a few transcripts displayed significant
changes but weak or modest correlations with Krt1-19
(that is, Fn1, Lama5, Lamc1, Itga7). Furthermore, al-
though the levels of a number of transcripts changed in
both the first and second tiers of defense, a smaller
number (that is, Agrn, Bgn, Fbn1, Col4a1, Col9a3,
Lama5, Lamb1, Lamb2, Itga4, Igtb2, Itgb4, Itgb6, and
Nid1) were significantly up-modulated, mainly in the
second tier of defense. Taken together, our transcrip-
tional profiling analysis suggests that, in a second tier of
defense modulation of transcript levels of a number of
ECM constituents are related to the HPC response.
However, some are regulated in both first and second
tiers of defense, while others are mainly modulated in
the second tier of defense.
A novel protease system with a potential role in ECM
remodeling during a hepatic progenitor cell response
Studies on the AAF/PHx protocol have shown that levels
of matrix metalloproteinases (MMP) 2 and 9, which di-
gest laminin and collagen IV, are increased in the HPC
response [13]. In this study, our transcriptional profiling
showed decreasing (Mmp2) or almost constant (Mmp9)levels over the period investigated (see Table 1 and panel
h in Additional file 2). However, significant modulation
of transcript levels related to the HPC response was
found for Mmp12, Mmp14, Mmp19, and Mmp23 but
only Mmp12 transcript levels showed a very strong cor-
relation with that of Krt1-19. Interestingly, a previous
microarray analysis using the AAF/PHx protocol in rats
has also indicated elevated transcript levels of St14 in
HPCs [20]. St14 encodes matriptase, a transmembrane
serine protease with broad-spectrum degrading capabil-
ities. It can activate the potent mitogen hepatocyte
growth factor (HGF encoded by Hgf ) [21]. Its substrates
additionally encompass ECM constituents, including
laminin, fibronectin, and collagen IV, as well as urokin-
ase plasminogen activator, plasminogen, hepsin, and kal-
likrein B1 (encoded by Plau, Plg, Hpn, and Klkb1).
Matriptase forms a functional unit with prostasin (en-
coded by Prss8) [22]. Two cognate inhibitors of matrip-
tase, the transmembrane serine proteases HAI-1 and
HAI-2 (encoded by Spint1 and Spint2) exist. In addition
to inhibiting matriptase activity, HAI-1 and HAI-2
localize matriptase to the cell surface, and inhibits HGF
activity through inhibition of hepatocyte growth factor
activator (encoded by Hgfac) [23-25]. By calculating
product–moment correlation coefficients of the signal
intensities for molecules in the matriptase system, we
found a strong or very strong correlation between the
up-modulated transcriptional profiles of Krt1-19 and
St14, Spint1, and Prss8 and a weak correlation with the
down-modulated profile of Spint2 in the second tier of
defense but only St14 and Spint2 were found to be sig-
nificantly modulated (P < 0.01) in our statistical analysis
(see Table 1, Additional file 1, and panel i in Additional
file 2). Therefore, we investigated the transcriptional
modulation of Spint1, Spint2, St14, Prss8, and Krt1-19
(see Figure 1A), using real-time RT-PCR on RNA iso-
lated from several rodent protocols of liver injury, that
is: (a) a 70% hepatectomy (PHx) as an inducer of mature
hepatocyte and cholangiocyte proliferation in a first tier
of defense, (b) induction of HPC-responses in a second
tier of defense using the AAF/PHx and choline-deficient,
ethionine-supplemented (CDE) protocols and (c) induc-
tion of mature cholangiocyte proliferation using a bile
duct ligation (BDL) protocol as a model of cholestatic
liver disease and a first tier of defense. Two control
groups, that is, untreated (control) rats and rats sub-
jected to a sham laparotomy operation (sham) were in-
cluded. Real-time RT-PCR analyses in the AAF/PHx
protocol confirmed trends obtained from the microarray
data. In fact, elevated expression levels of Spint1, St14,
Prss8, and Krt1-19 transcripts were particularly evident
in the two second tier of defense protocols mounting
HPC-responses. However, the analysis also showed
significant up-modulation of Spint1 transcript levels,
d Dlk1 / Nidogen 1/ Dapi
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a Matriptase / Dlk1 / Dapi
AAF/PHx day 9
b HAI -1/ Dlk1 / Dapi
AAF/PHx day 9
c Dlk1 / Nidogen 1/ Krt19
AAF/PHx day 9
e HAI -1/ Dlk1 / Dapi
Sham day 1
f HAI -1/ Dlk1 / Dapi
BDL day 14
gHAI -1/ Dlk1 / Dapi
AAF/PHx day 9
A
B
Krt1-19 mRNA fold change Spint1 mRNA fold change Spint2 mRNA fold change St14 mRNA fold change Prss8 mRNA fold change 
Figure 1 Expression of matriptase network in hepatic injury. (A) Real-time RT-PCR analysis. Elevated expression levels of Spint1, St14, Prss8,
and Krt1-19 transcripts were particularly evident in the two liver injury protocols with HPC-responses. While Krt1-19 transcripts were significantly
increased up to 7-fold on day 14 in the BDL protocol, HPC response showed the highest induction, with increases from 3- to 40-fold on days 1
through 9 in the AAF/PHx protocol and from 4- to 60-fold at weeks 1 through 4 in the CDE protocol. Similar expression patterns were obtained
for St14 and Spint1 transcripts. Where St14 was increased 2.6- to 7-fold in the PHx and BDL protocols, a 45- to 90-fold increase was observed on
week 4 in the CDE and on day 9 in the AAF/PHx protocols, respectively. Similarly, Spint1 reached a 90- to 105-fold increase on week 3 in the CDE
and day 9 in AAF/PHx protocols, whereas Prss8 increased 16- to 18-fold, respectively. In control and sham protocols, significant changes in gene
expression were not detected. Values are relative to the uninjured control group ± standard deviation (*P < 0.05; †P < 0.001). Very strong positive
correlations were observed between expression values for Spint1 and St14 and the progenitor cell marker Krt1-19. (b) Triple immunofluorescence
localized: (a) matriptase, (b) HAI-1, and (c) OV6/Krt19 to both the cholangiocytes and HPC response. (a-d) Dlk1 marked a subpopulation of
matriptase or HAI-1-positive cells in the HPC response. (c,d) Nidogen1 closely encircled the tortuous structures in the HPC response. (e-g) HAI-1
was expressed by cholangiocytes and HPCs regardless of type of hepatic insult. Dlk1, however, was only located to a subpopulation of cells in
the HPC response. Magnification: 10×; inserts 40×.
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the product–moment correlation coefficient of Ct-values
showed very strong positive correlation for Krt1-19 ver-
sus both Spint1 and St14. In conclusion, the real-time
RT-PCR analysis confirmed the data displayed by the
signal intensities in the microarray analysis. Our data
therefore underscore a possible important role of the
matriptase network in ECM remodeling, when a HPC
response is mounted in a second tier of defense to liver
injury.Computerized three-dimensional reconstruction of
hepatic progenitor cell response using Dlk1, HAI-1 and
nidogen1 as marker proteins for HPCs and ECM
Classical immunohistochemistry was employed to pin-
point the cellular localization of matriptase and HAI-1
(encoded by St14 and Spint1, respectively; see Additional
file 3). We studied livers from control, BDL day 14,
AAF/PHx day 9, and CDE week 3. Both proteins were
localized in membranes of cholangiocytes in the biliary
tree of control liver and in the BDL protocol. In the
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additionally localized to membranes of the HPC re-
sponse in the tortuous network of ductular structures
radiating from the portal area into the parenchyma.
To further characterize HAI-1 and matriptase expres-
sion in liver injury, double immunofluorescence on fro-
zen liver sections from sham day 1, BDL day 14 and
AAF/PHx day 9, were conducted relative to Dlk1, a
marker of fetal hepatocyte-like HPCs. As a result of
cross-reaction between secondary antibodies with pri-
mary sheep and goat antibodies, co-staining HAI-1
(goat) with matriptase (sheep) was not possible. The
analysis revealed that HAI-1 and matriptase were ex-
pressed in the basolateral membranes of cholangiocytes
of the biliary tree and HPCs. Interestingly, only a sub-
population of HAI-1-positive cells co-expressed Dlk1
(see Figure 1B, panels a, b, e, f, and g). A similar distri-
bution of Dlk1-positive cells was found within the OV6/
Krt19-positive HPC response (see Figure 1B, panels c
and d). Dlk1-expressing HPCs were never detected
within untreated or sham liver (see Figure 1B, panel e).
Furthermore, Dlk1 expressing cells could not be de-
tected in the biliary tree after a ligation of the common
bile duct (see Figure 1B, panel f ). In all injury protocols,
as well as in untreated liver, nidogen1 staining was de-
tected in the ECM on which cholangiocytes and HPCs
were situated (see Figure 1B, panels c and d and
Figure 2, panels i-l (inserts showing canals of Hering in
high magnification)).
It has previously been reported that Dlk1 is expressed
in a subpopulation of the HPC response [18,26]. In an
attempt to visualize the localization of Dlk1 expressing
populations of fetal hepatocyte-like HPCs in a second
tier of defense, we reconstructed the HPC response in
three dimensions. Serial sections representing 208 μm of
hepatic tissue from either untreated or AAF/PHx day 9
livers were stained by conventional immunohistochemis-
try for Dlk1, HAI-1, and nidogen1. Stained sections
were translated to digital volumetric and segmentation
based three-dimensional reconstructions (see Figure 3).
Additional movie files show this in more detail (see
Additional files 4 and 5). The reconstructions demon-
strated that branching portal veins and accompanying
portal bile ducts in one end of the stack directly
coupled two portal areas that appeared distinct in fol-
lowing sections. In untreated as well AAF/PHx day 9
livers, nidogen1 closely circumscribed the portal vessels,
bile ducts, and HPC response, whereas HAI-1 marked
the two latter. Our computerized three-dimensional re-
construction visualized the intricate network of tortuous
structures of HAI-1-positive HPCs embedded in an
ECM microenvironment that expands into the hepatic
parenchyma in the AAF/PHx protocol during a second
tier of defense. Furthermore, in the AAF/PHx day 9 liver,Dlk1-positive HPCs located in smaller clusters at the
portal area periphery within a HAI-1-positive HPC re-
sponse. At no point throughout the image stacks did
cells in the portal bile duct stain for Dlk1. Neither did
any cell in the untreated liver express Dlk1. These data
indicate that Dlk1 selectively marks a peripheral fetal
hepatocyte-like subpopulation, whereas HAI-1 is ex-
pressed in cholangiocytes in normal liver as well as in
the ductular epithelial cells of the entire HPC response.The molecular composition of ECM in different models of
liver injury
Finally, we wanted to test the hypothesis that a selective
difference in the molecular composition of the ECM
would signify the activation of the HPC response in a
second tier of defense. For this purpose, we conducted
double immunofluorescence on liver sections from BDL
day 14 (a model of a first tier of defense with respect to
proliferation of cholangiocytes in the biliary tree) and
AAF/PHx day 9 (as a model of the HPC response in a
second tier of defense) and compared the results for
those with uninjured liver from sham day 1. We investi-
gated expression of the extracellular matrix molecules
Collagen1a1, laminin, and nidogen1 in relation to HAI-1
and Dlk1 (see Figure 2) as well as integrin-β6 and agrin
in relation to OV6/Krt19 (see Additional file 6). Further
immunofluorescence characterization of differentially
modulated ECM constituents, such as Lamb1, Col4a1,
and Col5a1, was attempted but hampered by the avail-
ability of appropriate antibodies.
As illustrated in Figure 1B, panels b and e-g, immuno-
fluorescence detection of HAI-1 and Dlk1 clearly re-
vealed HAI-1 expression in the cholangiocytes of livers
from sham and BDL protocols, whereas Dlk1 was un-
detectable. Similar results were found when integrin-β6
was combined with Dlk1 (see panels a and b in
Additional file 6). However, whereas HAI-1 and integrin-
β6 staining decorated cells in the entire intricate network
of tortuous structures of HPCs as well as cholangiocytes
in the large bile ducts in the AAF/PHx protocol, Dlk1
marked a peripheral subpopulation of fetal hepatocyte-like
cells in the structures containing HPCs (see Figure 1B,
panel g and panel d in Additional file 6). Double immuno-
fluorescence analysis of HAI-1 with Collagen1a1 (see
Figure 2, panels a-c), laminins (see Figure 2, panels e-g),
and nidogen1 (see Figure 2, panels i-k) demonstrated
ECM deposition around portal area vessels, the biliary tree
and the tortuous structures of HPCs. Collagen1a1 add-
itionally stained the portal mesenchyma and was found
scattered along the sinusoids. Double immunofluores-
cence of the ECM structural constituents with Dlk1 in
the AAF/PHx protocol depicted the HPC response as
ductular structures, some, but not all, harboring
Figure 2 Protein of the basal lamina and other ECM structural constituents are localized similarly across rat hepatic injury protocols.
In the sham, BDL, and AAF/PHx protocols, (a-d) Collagen1a1, (e-h) laminin, and (i-l) nidogen1 stained the portal vein endothelia and closely
circumscribed cells in the biliary tree and HPC response. Collagen1a1 deposition was additionally observed in the parenchyma. In the canals of
Hering, staining for HAI-1 often extended beyond the extracellular matrix (inserts in c,g,j). (d,h,l) The Dlk1 expressing subpopulation of cells in
the AAF/PHx protocol was always in contact with the extracellular matrix. In the BDL and AAF/PHx protocols, (n-p) Ki67-positive cells were observed
both within (n,o) the HAI-1- and (p) the Dlk1-positive cell populations. Ki67-positive cells were, however, rarely detected in (m) the sham protocol. In the
sham protocol, (q) desmin prominently stained the portal vein endothelia and the portal artery, while faintly marking occasional star-shaped cells near the
biliary tree or in the parenchyma. Regardless of injury type, in both the (r) BDL and (s,t) AAF/PHx protocols, numerous desmin-positive
star-shaped cells closely escorted the biliary tree and HPC response.
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d, h, and l).
The intermediate filament desmin marked the endo-
thelia in the portal area vessels and few cells scattered in
the parenchyma (see Figure 2, panels q-t). However, in
both the BDL and AAF/PHx protocols, numerous star-shaped desmin-positive cells were closely associated with
the cholangiocytes in the biliary tree and the HPC re-
sponse. In sham day 1 liver, the marker Ki67 demon-
strated that few cells in the parenchyma and biliary tree
were proliferating. In the BDL and AAF/PHx protocols,
multiple Ki67-positive cells were detected in the HAI-1-
Figure 3 Three-dimensional reconstruction of injured rat liver mounting a HPC response. Three-dimensional (3D) reconstructions of
208 μm rat liver tissue demonstrated protein expression in control liver (A) and liver from day 9 in the AAF/PHx protocol (B). Hepatic tissues were
visualized by (a) volumetric rendering presenting the immunohistochemistry and (d,f,h) segmentation based reconstructions of lumina and
protein expression. These techniques are presented combined in subpanels b, c, e, g, i, and j. In control rat liver (A, a-j) and day 9 in the AAF/
PHx protocol (B, a-j) two portal areas merged in one end of the image stack (d) and continued as separate entities. Presented in green, lumina
of slender portal bile ducts (b) along the portal vein connecting the portal areas could be traced in both livers. Whereas Dlk1 localized peripherally to
the portal area in the AAF/PHx protocol (B;c,d) and was undetectable throughout the image stack from control liver (A;c,d), HAI-1 marked the
epithelial cells in the entire biliary tree (A, e and f) and the HPC response (B;e,f). In control liver (A;g,h) Nidogen1 was only expressed in the
portal area and circumscribed the biliary tree, and additionally embedded the HPC response in the AAF/PHx protocol (B;g,h). Combined staining
of HAI-1 and Nidogen1 emphasized nidogen1 deposition around the HAI-1, expressing cells in the bile epithelium (A,B;i), and clarified Dlk1 as a
marker of a subpopulation of HAI-1 expressing cells within the HPC response (B;j).
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ous structures of HPCs (see Figure 2, panels m-p).
Discussion
When liver regeneration through hepatocyte division is
arrested, dormant progenitor cells in the canals of Hering
are activated and give rise to intricate ductular structures
radiating into the parenchyma, in what has been termed
the second tier of defense to liver injury. These structurescontain proliferating HPCs capable of differentiating into
cholangiocytes or hepatocytes and are termed the HPC re-
sponse [1-6]. Little is known of the exact composition of
the microenvironment governing this form of regeneration,
but several cellular and molecular players have been identi-
fied. These include stellate cells, myofibroblasts, and Kupp-
fer cells, as well as cytokines and growth factors [9,27,28].
Previous studies support the proposition of an import-
ant role for the ECM in establishing specific hepatic
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of HPCs to tissue injury [6,13,15,29]. However, a detailed
scheme of the molecules involved in remodeling of the
ECM when the hepatic progenitor cell niche responds to
liver injury has not yet been established. The ECM is a
dynamic scaffold influencing several aspects of cellular
behavior, including growth, survival, and morphology,
partly through the integrin family of ECM receptors
[30,31]. Studies in different tissues across species have
clarified that the ECM constitutes an important part of
progenitor cell niches [7,8]. While certain microenviron-
ments in Drosophila, as expected, repress stem cell dif-
ferentiation and promote adherence to the niche [8],
even age-related differences in ECM composition
directly influence stem cell function [32]. To begin un-
derstanding the remodeling events in the ECM micro-
environment when HPCs are activated in a second tier
of defense to liver injury, we used the AAF/PHx protocol
to study transcriptional changes in ECM constituents
during three phases of an HPC response, that is, the ac-
tivation phase, the early proliferation and migration
phase, and the late proliferation and migration phase. In
the HPC response, the levels of numerous transcripts
encoding different subunits of collagens (that is, Col1a2,
Col3a1, Col4a1, Col5a1, Col5a2, Col6a1, Col6a3, Col8a1,
Col9a3, Col14a1, Col16a1), laminins (that is, Lamb1,
Lamb2), integrins (that is, Itga4, Itgb2, Itgb4, Itgb6), and
various other ECM structural components (that is, Agrn,
Bgn, Fbn1, Nid1, Sparc) showed significant changes and
strong or very strong correlations with the HPC-marker
Krt1-19. The levels of a few transcripts displayed signifi-
cant changes but weak or modest correlations with
Krt1-19 (that is, Fn1, Lama5, Lamc1, Itga7). Addition-
ally, although the levels of a number of these transcripts
changed in both the first and second tier of defense to
liver injury, Agrn, Bgn, Fbn1, Col4a1, Col9a3, Lama5,
Lamb1, Lamb2, Itga4, Igtb2, Itgb4, Itgb6, and Nid1 were
significantly up-modulated, mainly in the latter. We con-
clude that a number of basal lamina and ECM structural
constituents are modulated at the transcriptional level to
aid the evolution of a second-tier HPC response to liver
injury.
Two of the modulated structural constituents, laminin
and Collagen1, are well described in hepatic studies.
Where laminin is a recognized marker of the basal lam-
ina [33], the fibrillar Collagen1 heterotrimer is the main
component of scarring tissue in cirrhotic liver [34].
Nidogen1 and agrin represent a glycoprotein [35] and a
proteoglycan [36,37], respectively, both known to be im-
portant for ECM stabilization through their cross-
linking abilities. In our study, laminin and Collagen1
circumscribed the portal area blood vessels and the cho-
langiocytes in the biliary tree in normal liver. Collagen1-
positive stretches were additionally observed in theparenchyma, in what might be the space of Disse [33].
In the BDL protocol, where mature cholangiocyte prolif-
eration models cholestatic liver disease, and the AAF/
PHx protocol of HPC-driven regeneration, we observed
laminin and Collagen1 deposition around the biliary tree
and the intricate network of tortuous structures of
HPCs. In the HPC response, combined detection of
Dlk1 and laminin or Collagen1 consistently showed a
subpopulation of Dlk1-positive cells located in duct-like
stretches of ECM. The similarity of these Dlk1-positive
HPCs with fetal hepatocytes might indicate the presence
of a cellular hierarchy in the HPC response. Therefore,
this and previous studies document laminin [2,3,6] and
Collagen1 [15] deposition around HPCs, suggesting an
important role for these components in the HPC re-
sponse. Interestingly, in in vitro studies, opposed roles
for laminin and Collagen1 with respect to HPCs have
been observed. While laminin supports proliferation and
expansion, Collagen1 elicits growth arrest and differenti-
ation [38,39]. Moreover, a recent study indicated the re-
quirement for α1-containing laminin in committing
HPCs towards the cholangiocytic fate and establishing
apico-basal polarization, whereas α5-containing laminin
played a major role in mature bile duct formation [40].
In our studies, only Lama5 transcriptional levels were
changed significantly when a HPC response was stimu-
lated. However, a significant transcriptional modulation
was found for Lamb1, Lamb2, and Lambc1. The sequen-
tial and different actions of even structurally similar
laminins, possibly mediated through integrin β1-signaling,
emphasize the importance of our study deciphering
the time and spatial changes of the actual molecular
constituents of the ECM during a HPC response. Fu-
ture studies directed towards the identified ECM con-
stituents using cell lines in vitro as well as hepatic
injury models with transgenic animals will be needed
to elucidate further the microenvironment governing
an HPC response.
Our transcriptional profiling also revealed that tran-
scripts related to a novel protease system with functions
in ECM remodeling and composed of matriptase (St14)
and its associated protein HAI-1 (Spint1) were signifi-
cantly elevated in a HPC response. Matriptase and HAI-
1 are relatively undescribed in the liver. Previous studies
have localized matriptase and HAI-1 to the bile duct epi-
thelium and ductular reactions [41,42], while microarray
analyses have indicated elevated mRNA levels of St14 in
the HPC response [20]. Moreover, down-regulation of
HAI-1 and HAI-2 (encoded by Spint2) has recently been
associated with differentiation of hepatoblast-derived
cells into hepatocytes and cholangiocytes [42]. In our
study, HAI-1 and matriptase not only stained cholangio-
cytes in the biliary tree of adult control liver but also the
proliferating cholangiocytes in the BDL protocol and the
Vestentoft et al. Fibrogenesis & Tissue Repair 2013, 6:21 Page 12 of 16
http://www.fibrogenesis.com/content/6/1/21entire intricate network of tortuous structures of HPCs
in the AAF/PHx protocol. Dlk1 is a rare surface marker
of HPCs associated with less differentiated hepatocellu-
lar phenotypes [17,18]. Co-staining with HAI-1 demon-
strated that Dlk1 strikingly marked a subpopulation of
HAI-1-positive epithelial cells only present in the HPC
response. However, examining single sections of liver tis-
sue could mask underlying connections not immediately
apparent. We therefore applied three-dimensional re-
constructions to visualize 208 μm of hepatic tissue from
control and AAF/PHx treated rats. The reconstructions
in the AAF/PHx protocol illustrated that while two por-
tal areas connected within the image stack, the Dlk1/
HAI-1-positive cells were entirely located in peripheral
ductular structures connected to the larger bile ducts by
HAI-1-positive cells. We therefore hypothesize that the
AAF/PHx protocol gives rise to a subpopulation of HAI-
1 and Dlk1-expressing transit-amplifying cells that can
differentiate along the hepatocytic or cholangiocytic line-
ages in a sequence similar to that which has been ob-
served during liver development. This suggests the
presence of a cellular hierarchy in the activated progeni-
tor cell niche.
Assuming that the niche for HPCs is localized in ca-
nals of Hering, it appears to be sharply limited by the
deposition of Collagen1, laminin, nidogen1 and agrin, fa-
cilitating HPC adhesion, transit-amplification and early
cholangiocytic or hepatocellular differentiation reflected
by expression of HAI-1 alone (biliary) or HAI-1 and
Dlk1 in combination (hepatobiliary), a phenomenon
similar to that observed in Drosophila gonads [8]. Given
that the same ECM proteins are also deposited around
the biliary tree in the liver of untreated rats, the BDL
protocol as well as in the HPC response in the AAF/
PHx protocol, it seems conceivable that a main function
of the investigated ECM proteins is to serve a supportive
role for the biliary and hepatobiliary phenotypes, rather
than to induce differentiation.Conclusions
This study presents a number of ECM constituents that are
modulated at the transcriptional levels when a HPC re-
sponse is mounted in a second tier of defense to liver
injury. However, significant remodeling of extracellular
matrix components also occurs at the post-translational
level, involving protein processing by proteolysis. Further-
more, a number of different cell types apart from the biliary
cells and HPCs, such as hepatocytes, stellate cells and myo-
fibroblasts, are involved in the synthesis and processing of
ECM constituents. Future studies using novel cell-sorting
strategies and assays pinpointing post-translational modifi-
cations during ECM remodeling in the different animal
models are needed to fully understand the functional rolesof the identified ECM constituents in mounting and sup-
porting a HPC response.
Methods
Animal protocols
Male Fischer (F344) rats (6 to 8 weeks, Taconic Europe A/S
(Ry, Denmark)) were kept under standardized conditions
with access to food and water ad libitum. Liver injury was
induced by: (1) The PHx protocol, modeling a first tier of
defense, where surgical resection of the median and left lat-
eral liver lobes removed 70% of the liver mass and resulted
in proliferation of mature hepatocytes and cholangiocytes;
(2) the AAF/PHx protocol or a choline-deficient, ethionine-
supplemented (CDE-protocol) diet, both modeling a HPC
response in a second tier of defense. In brief, rats were
treated with 9 mg/kg/day 2-acetylaminofluorene by gavage
once daily for 9 days, interrupted at day 5 to perform a
70% hepatectomy, or fed a choline-deficient diet (ICN,
Costa Mesa, CA) supplemented with 0.165% DL-ethionine
(Sigma-Aldrich) in the drinking water; (3) the BDL proto-
col, a model of cholestatic liver disease and a first tier of
defense, where the common bile duct was tied with a non-
absorbable ligature, resulting in a ductular reaction of pro-
liferating mature cholangiocytes; and (4) control groups,
comprising: (a) a sham operation with laparotomy only
(sham) and (b) untreated animals (control). Groups of
three to six animals were sacrificed by cervical dislocation
at the time points indicated. Studies were approved by
The Danish Council for Supervision with Experimental
Animals (License Nr. 2004/561-843 and 2009/561-1632).
Transcriptional profiling
RNA isolation
Liver samples were homogenized by means of a TissueLy-
ser (Qiagen, Retsch, Germany) and total RNA was ex-
tracted using the Trizol Reagent (Invitrogen, Carlsbad, CA
USA). The RNA concentration was measured using a
NanoDrop ND-1000 spectrophotometer (NanoDrop Tech-
nologies, Inc., Wilmington, DE USA). The purity of ex-
tracted RNA was determined by the A260/A280 ratio, and
a ratio of 1.8 to 2.0 was considered acceptable. The integrity
of the RNA was confirmed on an Agilent 2100 Bioanalyzer
and its corresponding Lab-on-a-chip product ‘Agilent RNA
6000 Nano Kit’ (Agilent Technologies Inc., Santa Clara, CA
USA).
Illumina bead chip array analysis
Biotin-labeled cRNA was produced by linear amplification
(AMIL1791; Ambion, Austin, TX USA) using 200 ng of
quality-checked total RNA. Liver samples obtained from
rats treated according to the PHx or AAF/PHx protocols at
days 1, 5, and 9 post hepatectomy as well as from untreated
controls were prepared in triplicate from individual rats.
Chip hybridizations, washing, Cy3-streptavidin (Amersham
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performed on an Illumina BeadStation 500 (Illumina, San
Diego, CA USA) platform using reagents and following
protocols supplied by the manufacturer. cRNA (750 ng/
sample) were hybridized on Sentrix whole genome bead
chips RatRef-12 covering >22,000 RefSeq transcripts. Image
analysis and data extraction were performed automatically
using Illumina BeadScan Software 3.2 and the data set nor-
malized using quantile and background subtraction. The
analysis of differentially modulated genes was performed
using BRB-ArrayTools Version 4.3.1 developed by Dr.
Richard Simon and the BRB-ArrayTools Development
Team. Genes showing signal intensities over 75 were de-
fined to be differentially modulated if they were up- or
down-regulated with a P value below 0.01 (Students t test)
and a false discovery rate (FDR) < 5% when comparing con-
trol vs. PHx rats at days 1, 5, and 9 or AAF/PHx rats at
days 1, 5, and 9.
Real-time RT-PCR
cDNA synthesis was performed from 1 μg RNA per
sample using a high-capacity cDNA reverse transcription
kit with RNase inhibitor (Applied Biosystems, Foster
City CA, USA). The probe and primer design (see
Table 2), optimizations, PCR efficiency and real-time
RT-PCR were executed on an ABI 7300 real-time PCRTable 2 Applied primers and probes for real-time RT-PCR
Gene symbol Sequence
Krt19
1Primer forward 5′-GGC GCC ACC ATT GAG AACT-3′
1Primer reverse 5′-GCC AGG CGG GCA TTG-3′
1Probe 5′-FAM-CAA GAT AGT CCT ACA GAT
Spint1
1Primer forward 5′-GCA TCT ACT GCA AGG TGA CCA
1Primer reverse 5′-CCA CAG CTC AAC TTC TTC TGG A
2Probe 5′-FAM-TGT CAG TGT TAA GAG AAA
Spint2
1Primer forward 5′-TGC TCT GGG AAG CAG ATG TAT C
1Primer reverse 5′-TGC GAA CCA TTC GGA TCA G-3′
2Probe 5′-FAM-ACA AAA GCG GTG ATC C-M
St14
1Primer forward 5′-TGG CTG TGG AGC GAG TTG T-3′
1Primer reverse 5′-TGC CAC GGG CAT GGA-3′
1Probe 5′-FAM-CCT TCC CCA TTG ACC CCA G
Prss8
1Primer forward 5′-CAG TCA AGA ATC GGA GCT GAT
1Primer reverse 5′-CAC TGC CAC CAC CTG TGA TG-3′
1Probe 5′-FAM-CTG AAG CTT CCT GTG GTG C
Primer Express® Software Version 3 (Applied Biosystems) was employed to design p
prevent amplification of genomic DNA. 1TAG Copenhagen, Copenhagen, Denmark;system (Applied Biosystems). Genes were quantified sep-
arately in triplicates using TaqMan® 2x Universal PCR
Master Mix, No AmpErase® UNG (Applied Biosystems).
As transcription of classical housekeeping genes have been
shown to be modulated in liver injury models, which was
also evident from our transcriptional profiling analysis, we
opted to use equal amounts of reverse-transcribed quality-
controlled RNA from individual animals in the real-time
PCR analysis [43,44]. Results were obtained as threshold
cycle values. Expression levels of target genes in the sam-
ple groups relative to the control group were calculated as
fold changes.
Statistical analysis
Student’s t test in Microsoft Excel (http://www.microsoft.
com/) was used for comparisons of affected liver with con-
trol liver. GraphPad Prism 5 (http://www.graphpad.com/)
was used to calculate the product–moment correlation co-
efficient r and the coefficient of determination r2 between
transcript threshold cycle values.
Morphological analyses
Immunohistochemistry
Immunohistochemistry was performed on 4 μm formalin-
fixed paraffin-embedded liver sections (see Table 3). Anti-
gen retrieval was used as necessary and sections incubatedThreshold/concentration
0.052
100 nM
100 nM
CG-BHQ-1-3′ 200 nM
0.1
A-3′ 300 nM
T-3′ 300 nM
C-MGBNFQ-3′ 280 nM
0.1
-3′ 600 nM
600 nM
GBNFQ-3′ 100 nM
0.1
700 nM
700 nM
AA TGC-BHQ-1-3′ 240 nM
0.1
G-3′ 300 nM
300 nM
AG TCA TCC-BHQ-1-3′ 140 nM
rimers within different exons and probes covering exon-exon borders to
2Applied Biosystems, Foster City, CA USA.
Table 3 Applied antibodies for immunohistochemistry and immunofluorescence
Primary antibody Dilution Catalog number (clone) Secondary antibody Dilution Catalog number
Immunohistochemistry
1,*Matriptase 1:500 AF3946 7Vectastain Elite ABC Not applicable PK-6106
1,*HAI-1 1:500 AF1141 7Vectastain Elite ABC Not applicable PK-6105
2,+Nidogen-1 1:1000 ab14511 4Dako EnVision + System-HRP Not applicable K4008
3DLK1 1:50 N/A 4Dako EnVision + System-HRP Not applicable K4008
Immunofluorescence
1Integrin-β6 1:50 AF2389 8Alexa Fluor 488/594 1:400 A-11055/A-11058
1Agrin 1:100 AF550 8Alexa Fluor 488/594 1:400 A-11055/A-11058
1h/rOV-6 1:50 MAB2020 (Clone OV-6) 9Fluorescein 1:200 715-095-151
1HAI-1 1:50 AF1141 8Alexa Fluor 488/594 1:400 A-11055/A-11058
1DLK1 1:100 MAB114 (211309) 8Alexa Fluor 488 1:400 A-21141
3DLK1 1:250 N/A 8Alexa Fluor 594 1:400 A-21207
4Desmin 1:500 M0760 (D33) 9Fluorescein 1:200 715-096-151
4Laminin 1:2000 Z0097 8Alexa Fluor 594 1:400 A-11037/A-21207
5COL1A1 1:100 AB755p 8Alexa Fluor 594 1:400 A-11037/A-21207
2Nidogen-1 1:1500 ab14511 8Alexa Fluor 594 1:400 A-11037/A-21207
6Ki67 1:2000 NCL-Ki67p 8Alexa Fluor 594 1:400 A-11037/A-21207
1R&D Systems, Inc. Minneapolis, MN USA; 2AbCAM, Cambridge, UK; 3Polyclonal rabbit antibody; 4Dako A/S, Glostrup, Denmark; 5Milipore, Billerica, MA USA; 6Leica
Microsystems Inc., Buffalo Grove, IL USA; 7Vector laboratories, Burlingame, CA USA; 8Life Technologies Europe BV, Nærum, Denmark; 9Jackson ImmunoResearch
Europe Ltd., Suffolk, UK; *Sections were boiled in retrieval solution (St14) or retrieval solution, pH9 (Spint1) (Dako, catalog number S2367/S1699) for 20 min in a
microwave oven and let to cool to room temperature for 20 min. +Sections were digested in proteinase K for 2.5 minutes at room temperature (Dako, catalog
number S3020).
Vestentoft et al. Fibrogenesis & Tissue Repair 2013, 6:21 Page 14 of 16
http://www.fibrogenesis.com/content/6/1/21with primary antibodies overnight at 4°C. Primary antibody
binding was visualized by means of appropriate Vectastain
Elite ABC reagent kits (Vector laboratories, Inc. Burlingame,
CA USA) using diaminobenzidine (Sigma-Aldrich, Saint
Louis, MO USA) as substrate chromogen and counter-
stained with Mayer’s hematoxylin.
Immunofluorescence
For immunofluorescence analysis, 8 μm cryosections
were fixed in 4% paraformaldehyde in phosphate buff-
ered saline and incubated with primary antibodies over-
night at 4°C (see Table 3). Primary antibody binding
was visualized using appropriate Alexa Fluor (Invitrogen)
or Fluorescein (Jackson ImmunoResearch Europe Ltd.,
Suffolk, UK) conjugated antibodies and sections were
mounted with Prolong Gold anti-fade reagent with Dapi
(Invitrogen).
Computer-assisted three-dimensional reconstructions
Reconstruction of protein expression in rat liver in three di-
mensions was carried out using two previously developed
protocols [19]. Briefly, 52 consecutive 4 μm thick sections
were cut from formalin-fixed paraffin-embedded liver,
representing a total length of 208 μm hepatic tissue. Every
third section was stained by immunohistochemistry for
Dlk1, HAI-1 or nidogen1 (see Table 3). Immunostained
sections were digitized in tagged image file format (.tiff) at10× magnification (894 × 668 μm) using a Leica DC300 FX
CCD camera (24-bit red-green-blue color depths, 1392 ×
1040 pixels) attached to a Leica DM4000 B microscope.
Protein expression in the stack of aligned images was
visualized in the software platform ‘Amira’ version 5.3.3
(www.amira.com) using two approaches; volume and
segmentation based surface rendering, respectively.Additional files
Additional file 1: Table of genes encoding ECM constituents
differentially expressed among classes in a first tier or second tier
of defense using the PHx and AAF/PHx protocols as model systems.
The analysis of differentially modulated genes was performed using
BRB-ArrayTools Version 4.3.1 developed by Dr. Richard Simon and the
BRB-ArrayTools Development Team. Genes showing signal intensities over
75 were defined to be differentially modulated if they were up- or down-
regulated with a P value below 0.01 (Students t test) and a false discovery
rate (FDR) < 5% when comparing control vs. PHx rats at days 1, 5, and 9
or AAF/PHx rats at days 1, 5, and 9.
Additional file 2: Graphic illustration of signal intensities for genes
encoding ECM constituents differentially expressed among classes
in a first tier or second tier of defense using the PHx and AAF/PHx
protocols as model systems. Presentations of selected gene expression
data from livers of control rats and rats subjected to the 2-
acetylaminofluorene/70% partial hepatectomy protocol of progenitor cell
activation. Transcripts are categorized according to function: (a) epithelial
(oval) cell markers; (b) mesenchymal cell markers; (c,d) auxiliary proteins;
(e) collagens; (f) laminins; (g) integrins; (h) matrix metallo peptidases and
inhibitors; (i) and matriptase network components. Linear regressions and
correlation values were calculated between signal intensities for
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http://www.fibrogenesis.com/content/6/1/21transcripts versus the hepatic progenitor cell marker Krt19 (Krt19) or the
mesenchymal cell marker desmin (Des). Transcripts with signal intensities
below 75 were disregarded. Data are presented as ‘signal intensity’ ±
standard error of the mean).
Additional file 3: Matriptase and HAI-1 highlights the
cholangiocytic or biliary lineage. Photomicrographs showing
expression of (a) matriptase and (e) its cognate inhibitor HAI-1 in the
epithelial cells of the biliary tree in control liver. Correspondingly, (b-d)
matriptase and (f-h) HAI-1 mark the epithelial cells in the biliary tree of
(b,f) bile duct ligated rat liver and the HPC response in two protocols of
hepatic progenitor cell activation; (c,g) the 2-acetylaminofluorene/70%
partial hepatectomy and (d,h) choline-supplemented ethionine-deficient
diet, respectively. Magnification 40×.
Additional file 4: 3D-reconstruction of a portal area from control
rat liver. Rotating volumetric rendering depicting aligned
immunohistochemical staining for (A) HAI-1, Dlk1 and nidogen1. (B-D)
Rotating segmentation based reconstructions of portal vessel lumina and
protein expression.
Additional file 5: 3D-reconstruction of a portal area on day 9 in
2-acetylaminofluorene/70% partial hepatectomized liver. Rotating
volumetric rendering depicting aligned immunohistochemical staining
for (A) HAI-1, Dlk1 and nidogen1. (B-D) Rotating segmentation based
reconstructions of portal vessel lumina and protein expression.
Additional file 6: Expression of investigated proteins is similar
across rat hepatic injury protocols. (a-d) Integrin-β6 and (a,b) OV6/
Krt19 mark epithelial cells in the biliary tree in (a) sham operated and
(b) bile duct ligated (BDL) rats, respectively. (c,d) Similar expression for
integrin-β6 is observed in the 2-acetylaminofluorene/70% partial
hepatectomy (AAF/PHx) protocol with a hepatic progenitor cell response.
(e) Agrin highlights the portal vein endothelia, portal artery and encloses
the biliary tree in sham operated liver. In both (f) the BDL and (g) AAF/
PHx- protocols, agrin escorts OV-6/Krt19-positive cells. (inserts in f,g). OV6/
Krt19- or Integrin-β6-positive terminal cells in the canal of Hering
penetrating into the lobules frequently extend beyond deposited agrin.
(h) Dlk1-positive subpopulations in HPC response are enclosed by agrin,
(insert in h) the latter forming tubular structures depicting the extent of
the ductular reactions. Magnification 10×, inserts 40×.
Abbreviations
AAF/PHx: 2-acetylaminofluorene (AAF) combined with 70% partial
hepatectomy; BDL: Bile duct ligation; CDE: Choline-deficient, ethionine-
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discovery rate; HAI: Hepatocyte growth factor activator inhibitor;
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of metalloproteinase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HCB, PSV, and SST conceived the study. PJ and HCB designed and executed
the animal studies. JBA, MR, SST, PSV, and HCB performed and analyzed the
transcriptional profiles. PSV, TJ, JB, and LKV optimized and performed the
qRT-PCR analyses. PSV, TATT, LMG, and CHJ optimized and performed the
immunohistochemistry and immunofluorescence experiments. PSV
developed and performed the computer-assisted three-dimensional
reconstructions. All authors contributed to the writing of the paper and
approved the final version.
Acknowledgements
The authors thank Bjørg Krog for excellent technical assistance and Dr. Peter
Nagy, Semmelweis Medical University, Hungary, for valuable criticism of the
manuscript. The study was supported by grants to HCB from the Danish
Medical Research Council, Direktør Jacob Madsen and Hustru Olga Madsen’s
Fond, Løvens Kemiske Fabriks Forskningsfond, Augustinus Fonden, Beckett-
Fonden, Aase og Ejnar Danielsen’s Fond, Læge Sofus Carl Emil Friis og hustruOlga Doris Friis’s legat, Vera og Carl Johan Michaelsen’s Fond, Savværksejer
Jeppe Juhl og hustru Ovita Juhls Mindefond.
Author details
1Department of Cellular and Molecular Medicine, Faculty of Health and
Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200
Copenhagen, Denmark. 2Laboratory of Experimental Carcinogenesis, National
Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 3The Novo
Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health
Sciences, University of Copenhagen, Copenhagen, Denmark. 4Laboratory of
Molecular and Cellular Cardiology, Department of Clinical Biochemistry and
Pharmacology, Odense University Hospital, Odense, Denmark. 5Department
of Cardiovascular and Renal Research, University of Southern Denmark,
Odense, Denmark.
Received: 26 July 2013 Accepted: 27 November 2013
Published: 20 December 2013References
1. Riehle KJ, Dan YY, Campbell JS, Fausto N: New concepts in liver
regeneration. J Gastroenterol Hepatol 2011, 26(Suppl 1):203–212.
2. Paku S, Schnur J, Nagy P, Thorgeirsson SS: Origin and structural evolution
of the early proliferating oval cells in rat liver. Am J Pathol 2001,
158:1313–1323.
3. Paku S, Nagy P, Kopper L, Thorgeirsson SS: 2-acetylaminofluorene dose-
dependent differentiation of rat oval cells into hepatocytes: confocal
and electron microscopic studies. Hepatology 2004, 39:1353–1361.
4. Theise ND, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L, Kumar A,
Crawford JM: The canals of Hering and hepatic stem cells in humans.
Hepatology 1999, 30:1425–1433.
5. Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise
ND: The hepatic stem cell niche: identification by label-retaining cell
assay. Hepatology 2008, 47:1994–2002.
6. Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott R, Clayton E,
Andreone P, Bernardi M, Golding M, Alison MR, Iredale JP, Forbes SJ:
Characterisation of a stereotypical cellular and extracellular adult liver
progenitor cell niche in rodents and diseased human liver.
Gut 2010, 59:645–654.
7. Fuchs E, Tumbar T, Guasch G: Socializing with the neighbors: stem cells
and their niche. Cell 2004, 116:769–778.
8. Losick VP, Morris LX, Fox DT, Spradling A: Drosophila stem cell niches: a
decade of discovery suggests a unified view of stem cell regulation.
Dev Cell 2011, 21:159–171.
9. Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC: Progenitor cells in
liver regeneration: molecular responses controlling their activation and
expansion. APMIS 2005, 113:876–902.
10. Pi L, Oh SH, Shupe T, Petersen BE: Role of connective tissue growth factor
in oval cell response during liver regeneration after 2-AAF/PHx in rats.
Gastroenterology 2005, 128:2077–2088.
11. Pi L, Ding X, Jorgensen M, Pan JJ, Oh SH, Pintilie D, Brown A, Song WY,
Petersen BE: Connective tissue growth factor with a novel fibronectin
binding site promotes cell adhesion and migration during rat oval cell
activation. Hepatology 2008, 47:996–1004.
12. Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS,
Knight B, Yeoh GC, Fausto N, Parks WT: Transforming growth factor-β
differentially regulates oval cell and hepatocyte proliferation.
Hepatology 2007, 45:31–41.
13. Pham VT, Couchie D, Martin-Garcia N, Laperche Y, Zafrani ES, Mavier P:
Expression of matrix metalloproteinase-2 and −9 and of tissue inhibitor
of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Matrix Biol 2008, 27:674–681.
14. Pellicoro A, Aucott RL, Ramachandran P, Robson AJ, Fallowfield JA,
Snowdon VK, Hartland SN, Vernon M, Duffield JS, Benyon RC, Forbes SJ,
Iredale JP: Elastin accumulation is regulated at the level of degradation
by macrophage metalloelastase (MMP-12) during experimental liver
fibrosis. Hepatology 2012, 55:1965–1975.
15. Van Hul NK, Abarca-Quinones J, Sempoux C, Horsmans Y, Leclercq IA:
Relation between liver progenitor cell expansion and extracellular matrix
deposition in a CDE-induced murine model of chronic liver injury.
Hepatology 2009, 49:1625–1635.
Vestentoft et al. Fibrogenesis & Tissue Repair 2013, 6:21 Page 16 of 16
http://www.fibrogenesis.com/content/6/1/2116. Duncan AW, Dorrell C, Grompe M: Stem cells and liver regeneration.
Gastroenterology 2009, 137:466–481.
17. Jelnes P, Santoni-Rugiu E, Rasmussen M, Friis SL, Nielsen JH, Tygstrup N,
Bisgaard HC: Remarkable heterogeneity displayed by oval cells in rat and
mouse models of stem cell-mediated liver regeneration. Hepatology 2007,
45:1462–1470.
18. Jensen CH, Jauho EI, Santoni-Rugiu E, Holmskov U, Teisner B, Tygstrup N,
Bisgaard HC: Transit-amplifying ductular (oval) cells and their hepatocytic
progeny are characterized by a novel and distinctive expression of
delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol 2004,
164:1347–1359.
19. Vestentoft PS, Jelnes P, Hopkinson BM, Vainer B, Møllgård K, Quistorff B,
Bisgaard HC: Three-dimensional reconstructions of intrahepatic bile duct
tubulogenesis in human liver. BMC Dev Biol 2011, 11:56.
20. Yovchev MI, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD:
Identification of adult hepatic progenitor cells capable of repopulating
injured rat liver. Hepatology 2008, 47:636–647.
21. Lee SL, Dickson RB, Lin CY: Activation of hepatocyte growth factor and
urokinase/plasminogen activator by matriptase, an epithelial membrane
serine protease. J Biol Chem 2000, 275:36720–36725.
22. Friis S, Uzzun Sales K, Godiksen S, Peters DE, Lin CY, Vogel LK, Bugge TH:
A matriptase-prostasin reciprocal zymogen activation complex with
unique features: prostasin as a non-enzymatic co-factor for matriptase
activation. J Biol Chem 2013, 288:19028–19039.
23. Chen YW, Wang JK, Chou FP, Chen CY, Rorke EA, Chen LM, Chai KX, Eckert
RL, Johnson MD, Lin CY: Regulation of the matriptase-prostasin cell
surface proteolytic cascade by hepatocyte growth factor activator
inhibitor-1 during epidermal differentiation. J Biol Chem 2010,
285:31755–31762.
24. Szabo R, Hobson JP, List K, Molinolo A, Lin CY, Bugge TH: Potent inhibition
and global co-localization implicate the transmembrane Kunitz-type
serine protease inhibitor hepatocyte growth factor activator inhibitor-2
in the regulation of epithelial matriptase activity. J Biol Chem 2008,
283:29495–29504.
25. Larsen BR, Steffensen SD, Nielsen NV, Friis S, Godiksen S, Bornholdt J,
Soendergaard C, Nonboe AW, Andersen MN, Poulsen SS, Szabo R, Bugge
TH, Lin CY, Skovbjerg H, Jensen JK, Vogel LK: Hepatocyte growth factor
activator inhibitor-2 prevents shedding of matriptase. Exp Cell Res 2013,
319:918–929.
26. Tanimizu N, Tsujimura T, Takahide K, Kodama T, Nakamura K, Miyajima A:
Expression of Dlk/Pref-1 defines a subpopulation in the oval cell
compartment of rat liver. Gene Expr Patterns 2004, 5:209–218.
27. Pintilie DG, Shupe TD, Oh SH, Salganik SV, Darwiche H, Petersen BE: Hepatic
stellate cells’ involvement in progenitor-mediated liver regeneration.
Lab Invest 2010, 90:1199–1208.
28. Dezso K, Jelnes P, László V, Baghy K, Bödör C, Paku S, Tygstrup N, Bisgaard
HC, Nagy P: Thy-1 is expressed in hepatic myofibroblasts and not oval
cells in stem cell-mediated liver regeneration. Am J Pathol 2007,
171:1529–1537.
29. Kallis YN, Robson AJ, Fallowfield JA, Thomas HC, Alison MR, Wright NA,
Goldin RD, Iredale JP, Forbes SJ: Remodelling of extracellular matrix is a
requirement for the hepatic progenitor cell response. Gut 2011,
60:525–533.
30. Daley WP, Peters SB, Larsen M: Extracellular matrix dynamics in
development and regenerative medicine. J Cell Sci 2008, 121:255–264.
31. van der Flier A, Sonnenberg A: Function and interactions of integrins.
Cell Tissue Res 2001, 305:285–298.
32. Sun Y, Li W, Lu Z, Chen R, Ling J, Ran Q, Jilka RL, Chen XD: Rescuing
replication and osteogenesis of aged mesenchymal stem cells by
exposure to a young extracellular matrix. FASEB J 2011, 25:1474–1485.
33. Ogawa K, Suzuki J, Mukai H, Mori M: Sequential changes of extracellular
matrix and proliferation of Ito cells with enhanced expression of desmin
and actin in focal hepatic injury. Am J Pathol 1986, 125:611–619.
34. Rojkind M, Giambrone MA, Biempica L: Collagen types in normal and
cirrhotic liver. Gastroenterology 1979, 76:710–719.
35. Ho MS, Bose K, Mokkapati S, Nischt R, Smyth N: Nidogens - extracellular
matrix linker molecules. Microsc Res Tech 2008, 71:387–395.
36. Tátrai P, Dudás J, Batmunkh E, Máthé M, Zalatnai A, Schaff Z, Ramadori G,
Kovalszky I: Agrin, a novel basement membrane component in human
and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
Lab Invest 2006, 86:1149–1160.37. Bezakova G, Ruegg MA: New insights into the roles of agrin. Nat Rev Mol
Cell Biol 2003, 4:295–308.
38. Clayton E, Forbes SJ: The isolation and in vitro expansion of hepatic Sca-1
progenitor cells. Biochem Biophys Res Commun 2009, 381:549–553.
39. McClelland R, Wauthier E, Uronis J, Reid L: Gradients in the liver’s
extracellular matrix chemistry from periportal to pericentral zones:
influence on human hepatic progenitors. Tissue Eng Part A 2008, 14:59–70.
40. Tanimizu N, Kikkawa Y, Mitaka T, Miyajima A: α1- and α5-containing
laminins regulate the development of bile ducts via β1-integrin signals.
J Biol Chem 2012, 287:28586–28597.
41. Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K,
Koono M: Distribution of hepatocyte growth factor activator inhibitor
type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in
simple columnar epithelium and its modulated expression in injured
and regenerative tissues. J Histochem Cytochem 1999, 47:673–682.
42. Huang HP, Chang MH, Chen YT, Hsu HY, Chiang CL, Cheng TS, Wu YM, Wu
MZ, Hsu YC, Shen CC, Lee CN, Chuang YH, Hong CL, Jeng YM, Chen PH,
Chen HL, Lee MS: Persistent elevation of hepatocyte growth factor
activator inhibitors in cholangiopathies affects liver fibrosis and
differentiation. Hepatology 2012, 55:161–172.
43. Bisgaard HC, Muller S, Nagy P, Rasmussen LJ, Thorgeirsson SS: Modulation
of the gene network connected to interferon-gamma in liver
regeneration from oval cells. Am J Pathol 1999, 155:1075–1085.
44. Bustin SA: Absolute quantification of mRNA using real-time reverse
transcription polymerase chain reaction assays. J Mol Endocrinol 2000,
25:169–193.
doi:10.1186/1755-1536-6-21
Cite this article as: Vestentoft et al.: Molecular constituents of the
extracellular matrix in rat liver mounting a hepatic progenitor cell
response for tissue repair. Fibrogenesis & Tissue Repair 2013 6:21.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
